These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35121210)

  • 61. Underdosed Direct Oral Anticoagulants in Atrial Fibrillation Patients Reduce Stroke Severity and Improve Outcome.
    Naganuma M; Inatomi Y; Yonehara T; Nakajima M; Ueda M
    Cerebrovasc Dis; 2022; 51(4):473-480. PubMed ID: 34929687
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Race/Ethnicity and Sex-Related Differences in Direct Oral Anticoagulant Initiation in Newly Diagnosed Atrial Fibrillation: A Retrospective Study of Medicare Data.
    Essien UR; Magnani JW; Chen N; Gellad WF; Fine MJ; Hernandez I
    J Natl Med Assoc; 2020 Feb; 112(1):103-108. PubMed ID: 32035755
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Safety of Intravenous Thrombolysis Among Patients Taking Direct Oral Anticoagulants: A Systematic Review and Meta-Analysis.
    Shahjouei S; Tsivgoulis G; Goyal N; Sadighi A; Mowla A; Wang M; Seiffge DJ; Zand R
    Stroke; 2020 Feb; 51(2):533-541. PubMed ID: 31884908
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease.
    Kimachi M; Furukawa TA; Kimachi K; Goto Y; Fukuma S; Fukuhara S
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011373. PubMed ID: 29105079
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Adequate Adherence to Direct Oral Anticoagulant is Associated with Reduced Ischemic Stroke Severity in Patients with Atrial Fibrillation.
    Yamashiro K; Kurita N; Tanaka R; Ueno Y; Miyamoto N; Hira K; Nakajima S; Urabe T; Hattori N
    J Stroke Cerebrovasc Dis; 2019 Jun; 28(6):1773-1780. PubMed ID: 30318259
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Risk of Recurrent Ischemic Stroke with Unintended Low-Dose Oral Anticoagulant Therapy and Optimal Timing of Review.
    Shinoda N; Mori M; Tamura S; Korosue K; Kose S; Kohmura E
    J Stroke Cerebrovasc Dis; 2018 Jun; 27(6):1546-1551. PubMed ID: 29395644
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Comparison of Low and Full Dose Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Renal Dysfunction (from a National Registry).
    Gurevitz C; Giladi E; Barsheshet A; Klempfner R; Goldenberg I; Kornowski R; Elis A
    Am J Cardiol; 2021 Nov; 159():87-93. PubMed ID: 34503821
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Real-World Adherence and Persistence to Direct Oral Anticoagulants in Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis.
    Ozaki AF; Choi AS; Le QT; Ko DT; Han JK; Park SS; Jackevicius CA
    Circ Cardiovasc Qual Outcomes; 2020 Mar; 13(3):e005969. PubMed ID: 32148102
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Drug levels and bleeding complications in atrial fibrillation patients treated with direct oral anticoagulants.
    Testa S; Legnani C; Antonucci E; Paoletti O; Dellanoce C; Cosmi B; Pengo V; Poli D; Morandini R; Testa R; Tripodi A; Palareti G;
    J Thromb Haemost; 2019 Jul; 17(7):1064-1072. PubMed ID: 31013383
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Safety and effectiveness of direct oral anticoagulants versus vitamin K antagonists: results from 3 Italian regions.
    Kirchmayer U; Narduzzi S; Mayer F; Tuccori M; Leoni O; Belleudi V; Di Martino M; Lallo A; Addis A; Davoli M
    Recenti Prog Med; 2019 Apr; 110(4):195-202. PubMed ID: 31066365
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The management of patients with acute ischemic stroke while on direct oral anticoagulants (DOACs): data from an Italian cohort and a proposed algorithm.
    Rota E; Testa L; Di Brigida G; Agosti S; Rovere ME; Risso R; Morelli N
    J Thromb Thrombolysis; 2020 Oct; 50(3):732-738. PubMed ID: 32303943
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Inappropriate Dosing of Direct Oral Anticoagulants in Patients with Atrial Fibrillation.
    Sugrue A; Sanborn D; Amin M; Farwati M; Sridhar H; Ahmed A; Mehta R; Siontis KC; Mulpuru SK; Deshmukh AJ; Gersh BJ; Asirvatham SJ; Madhavan M
    Am J Cardiol; 2021 Apr; 144():52-59. PubMed ID: 33385355
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Low drug levels and thrombotic complications in high-risk atrial fibrillation patients treated with direct oral anticoagulants.
    Testa S; Paoletti O; Legnani C; Dellanoce C; Antonucci E; Cosmi B; Pengo V; Poli D; Morandini R; Testa R; Tripodi A; Palareti G
    J Thromb Haemost; 2018 May; 16(5):842-848. PubMed ID: 29532628
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Use of oral anticoagulants and its associated factors among nonvalvular atrial fibrillation patients with new-onset acute ischemic stroke: A report from the China Atrial Fibrillation Registry study.
    Wang JR; Du X; Dong JZ; Chang SS; Jiang C; Sang CH; Long DY; Tang RB; Zhang HB; Guo JC; Wen YM; He L; Ma CS
    Clin Cardiol; 2022 Jan; 45(1):60-67. PubMed ID: 34952974
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Prior Anticoagulation in Patients with Ischemic Stroke and Atrial Fibrillation.
    Meinel TR; Branca M; De Marchis GM; Nedeltchev K; Kahles T; Bonati L; Arnold M; Heldner MR; Jung S; Carrera E; Dirren E; Michel P; Strambo D; Cereda CW; Bianco G; Kägi G; Vehoff J; Katan M; Bolognese M; Backhaus R; Salmen S; Albert S; Medlin F; Berger C; Schelosky L; Renaud S; Niederhauser J; Bonvin C; Schaerer M; Mono ML; Rodic B; Tarnutzer AA; Mordasini P; Gralla J; Kaesmacher J; Engelter S; Fischer U; Seiffge DJ;
    Ann Neurol; 2021 Jan; 89(1):42-53. PubMed ID: 32996627
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Quality of direct oral anticoagulant prescribing in elderly patients with non-valvular atrial fibrillation: results from a large urban health system.
    Grant SJ; Kothari S; Gimotty PA; Gooneratne NS; Cuker A
    J Thromb Thrombolysis; 2018 Jul; 46(1):1-6. PubMed ID: 29611105
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Baseline Characteristics of Elderly Japanese Patients Aged ≥75 Years With Non-Valvular Atrial Fibrillation and a History of Stroke　- ANAFIE Registry.
    Kanemaru K; Yoshimoto T; Inoue H; Yamashita T; Akao M; Atarashi H; Ikeda T; Okumura K; Koretsune Y; Shimizu W; Tsutsui H; Hirayama A; Yasaka M; Yamaguchi T; Teramukai S; Kimura T; Kaburagi J; Takita A; Kusano K; Toyoda K;
    Circ J; 2020 Feb; 84(3):516-523. PubMed ID: 31983727
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Prescription frequency and predictors for the use of novel direct oral anticoagulants for secondary stroke prevention in the first year after their marketing in Europe--a multicentric evaluation.
    Luger S; Hohmann C; Kraft P; Halmer R; Gunreben I; Neumann-Haefelin T; Kleinschnitz C; Walter S; Haripyan V; Steinmetz H; Foerch C; Pfeilschifter W
    Int J Stroke; 2014 Jul; 9(5):569-75. PubMed ID: 24828272
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Direct oral anticoagulants in the early phase of non valvular atrial fibrillation-related acute ischemic stroke: focus on real life studies.
    Masotti L; Grifoni E; Dei A; Vannucchi V; Moroni F; Panigada G; Spolveri S; Landini G
    J Thromb Thrombolysis; 2019 Feb; 47(2):292-300. PubMed ID: 30470967
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Anticoagulant Initiation During Hospital Admissions for Atrial Fibrillation in South-East Queensland, Australia.
    Rathinam I; Anoopkumar-Dukie S; Badrick T; Teasdale T; Bernaitis N
    Heart Lung Circ; 2020 Sep; 29(9):e222-e230. PubMed ID: 32291155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.